Despite these possibilities, the boom in new drugs is likely to continue benefiting the industry and more importantly, the patients anxiously waiting for these new treatments.
Category: NASDAQ:SHPG
Takeda Acquisition Of Shire May Bode Well For R&D Staff
“We think that the fit is very strong between Takeda and Shire. We foresee minimal disruption on the R&D front.”
Sticker Shock: The Real Cost Of America’s 10 Most Expensive Drugs
The high price of pharmaceuticals have become a constant topic of discussion in the U.S. although very few consumers ever pay out-of-pocket prices thanks to insurance. But in the case that an individual had to pay list price, the following 10 drugs are…
